PA 15-10—sHB 5525
Public Health Committee
AN ACT CONCERNING CYTOMEGALOVIRUS
SUMMARY: Starting January 1, 2016, this act requires all health care institutions caring for newborn infants to test those who fail a newborn hearing screening for cytomegalovirus (CMV) (see BACKGROUND). It requires the testing to be done (1) within available appropriations and (2) as soon as is medically appropriate, unless, as allowed by law, their parents object on religious grounds.
Like existing law that requires these institutions to test newborn infants for cystic fibrosis, severe combined immunodeficiency disease, and critical congenital heart disease, the test for CMV is not part of the state's newborn screening program for genetic and metabolic disorders. That program, in addition to screening, directs parents of identified infants to counseling and treatment.
The act also requires health care institutions to report CMV cases confirmed by the screening to the Department of Public Health (DPH) in a form and manner the commissioner prescribes.
EFFECTIVE DATE: July 1, 2015
CMV is a type of herpesvirus, which places it in a group with chickenpox, shingles, and mononucleosis. Although usually harmless in healthy adults and children, CMV in newborns can lead to hearing loss or developmental disabilities. Transmission from mother to fetus occurs during pregnancy.
PA 15-242 makes a technical correction to the provision requiring health care institutions to report CMV cases confirmed by the screening to DPH.
OLR Tracking: ND; JKL; PF; BS